Bessemer Group
AMAG

Bessemer Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Bessemer Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-265
Closed -$6K – 1513
2016
Q1 		$6K Buy
265
+135
+104% +$3.2K ﹤0.01% 1242
2015
Q4 		$4K Sell
130
-49,696
-100% -$1.61M ﹤0.01% 1433
2015
Q3 		$1.98M Buy
+49,826
New +$3.09M 0.01% 416

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Bessemer Group's AMAG Position: Q2 2016 in Review

Bessemer Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2016, closing a stake of 265 shares — an estimated $6K sold.

Bessemer Group first reported a position in AMAG in Q3 2015 and held it in 3 quarters. The position peaked at $1.98M in Q3 2015. 165 funds tracked by Wall St. Rank hold AMAG as of Q2 2016.

  • Bessemer Group reported no remaining AMAG Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Bessemer Group sold 265 AMAG Pharmaceuticals shares in Q2 2016, an estimated $6K.
  • Bessemer Group first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • Bessemer Group's AMAG Pharmaceuticals position peaked at $1.98M in Q3 2015.
  • 165 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2016.

Based on Bessemer Group's 13F filing for Q2 2016, filed 11 Aug 2016.